Key result
Angiolymphoid hyperplasia with eosinophilia and Kimura's disease may represent extreme variants of the same disease.
This review explores the clinical and histopathological overlap between ALHE and Kimura's disease, questioning if they are variants of the same entity.
May prompt reevaluation of eosinophilic angioproliferative disorders as a spectrum; leaves open whether AHLE and Kimura's disease represent variants of one entity.
Summary Angiolymphoid hyperplasia with eosinophilia (ALHE) is a benign vascular neoplasm mainly affecting middle‐aged women. Lesions typically affect the head and neck region. ALHE is considered a distinct disease entity different from Kimura's disease, a benign reactive lymphoid proliferation that is predominantly seen in young Asian men although it can affect all ethnic groups. In contrast to ALHE, Kimura's disease is typically associated with peripheral blood eosinophilia, increased serum IgE and lymphadenopathy. Several case reports suggest an overlap between ALHE and Kimura's disease. We review the current literature and discuss whether AHLE and Kimura's disease might represent two extreme variants of the same disease entity.
No takes yet. Share an insight, caveat, or question.
Buder et al. (2013) conducted a review in Angiolymphoid hyperplasia with eosinophilia (ALHE) and Kimura's disease. Angiolymphoid hyperplasia with eosinophilia (ALHE) vs. Kimura's disease was evaluated. A review of the literature suggests that Angiolymphoid hyperplasia with eosinophilia and Kimura's disease might represent two extreme variants of the same disease entity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: